KRAS and BRAF Mutational Status can be Accurately Determined on Diagnostic Tissue Biopsies: An Analysis of Matched Biopsy and Resection Material from Patients with Colon Cancer in the NCRI FOxTROT trial
Автори: | , , , , , , , , , , , , , , , |
---|---|
Формат: | Conference item |
Опубліковано: |
2012
|
Резюме: |
---|